Workflow
Estrella Immunopharma(ESLA)
icon
Search documents
Estrella Immunopharma(ESLA) - 2022 Q1 - Quarterly Report
2022-05-15 16:00
Table of Contents | --- | |----------------------------------------------------------------------------| | | | Delaware | | (State or other jurisdiction of incorporation or organization) | | TradeUP Acquisition Corp. 437 Madison Avenue, 27th Floor | | New York, NY (Address of principal executive offices) | | --- | |-------| | | | | | | | | | | | | | | | | | | | | 10022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ...
Estrella Immunopharma(ESLA) - 2021 Q4 - Annual Report
2022-03-28 16:00
Table of Contents | --- | --- | |-----------------------------------------------------|-------| | | | | incorporation or organization) | | | 437 Madison Avenue, 27th Floor New York, NY | | | --- | |-------| | | | | | | | | | | | | | | | | | | 10022 | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------| | Titl ...
Estrella Immunopharma(ESLA) - 2021 Q3 - Quarterly Report
2021-11-09 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40608 TradeUP Acquisition Corp. (Exact name of registrant as specified in its charter) 85-1314502 New Yor ...